Evaluation of liver tissues from patients with MASLD and HFD‐fed mice revealed an upregulation of the proinflammatory marker CK2α and downregulation of the mitophagy receptor FUNDC1. This evidence concerns the gene FUNDC1 and metabolic dysfunction-associated steatotic liver disease.